This dataset contains a list of accession numbers of SARS-CoV-2 genomes obtained from 76 patients at NYU Langone Health who were fully vaccinated with the BNT162b2 (Pfizer/BioNTech), mRNA-1273 (Moderna), or JNJ-78436735 (Janssen) COVID-19 mRNA vaccines but had breakthrough infections between February 1 and April 30, 2021. 37 were male and 39 were female; the median age of patients was 48 years. There...

The Novel Coronavirus Illness Patient Report (NCIPR) dataset includes survey responses from 2,212 confirmed COVID-19 patients aged 18 to 98 who were treated at NYU Langone Health facilities between February 2020 and March 2021 and consented to the survey. Survey invitations were distributed two waves: once in February 2021 and once in March 2021. Between waves, 9 new items were added to the survey...

Investigators obtained high quality SARS-CoV-2 sequences from 132 vaccinated and 283 unvaccinated individuals who were seen at NYU Langone Health facilities between May 1, 2021 and August 3, 2021. Fully vaccinated individuals received either two doses of the BNT162b2 (Pfizer/BioNTech) or mRNA-1273 (Moderna) vaccines, or a single-dose of the COVID-19 Janssen vaccine. Breakthrough infections were defined...

To study and compare longitudinal immune responses to two-dose BNT162b2 mRNA vaccinations, investigators recruited 15 adults with a history of laboratory-confirmed COVID-19 and 21 adults who did not have COVID-19. Participants' ages ranged from 21 to 65 years old. Peripheral immune responses were assessed via blood samples drawn before and after each vaccine dose. A total of five samples were collected...

The NYC COVID-19 Community Health Resources and Needs Assessment (CHRNA) survey was a collaboration between the NYU Center for the Study of Asian American Health, the Coalition for Asian American Children and Families, the Chinese-American Planning Council, and 28 community partners. The COVID-19 CHRNA survey was developed to understand the impact of the COVID-19 pandemic on the Asian American, Hispanic,...

To investigate immune responses to SARS-CoV-2 antigens under various inflammatory conditions, researchers collected blood samples from five adult patients seen at NYU Langone Health with lab-confirmed cases of acute COVID-19 and from nine healthy adults (seven who had received the BNT162b2 mRNA vaccine and two with no prior exposure to SARS-CoV-2). Samples were obtained at multiple time points. Patients...

This study compared SARS-CoV-2 sequences that were collected from infected patients (n=2,397) who were seen at NYU Langone Health facilities and globally (n=24,060 sequences in GISAID) between August 1, 2022, and February 4, 2023 to understand the proliferation of Omicron strain XBB.1.5. Active SARS-CoV-2 infection was confirmed with positive real-time (RT)-qPCR testing. To assess the association between...

This is a prospective, two-year study of immunity against SARS-CoV-2 in multiple sclerosis patients receiving ocrelizumab (OCR) at the time of COVID vaccination. Researchers recruited 60 patients (aged 18-65) from the NYU MS Comprehensive Care Center in New York City and the Rocky Mountain MS Center at the University of Colorado Anschutz Medical Center in Aurora, CO. Participants provided blood samples...